{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-26-032242","form_type":"8-K","ticker":"AURX","cik":"0001091596","company_name":"Nuo Therapeutics, Inc.","filed_at":"2026-10-06T20:57:28+00:00","discovered_at":"2026-10-06T20:58:00.311730+00:00","generated_at":"2026-10-12T16:11:07.234799+00:00","sec_items":["1.01","2.03","3.02","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Nuo Therapeutics closes $325,000 Second Funding, reaching $2,000,000 total loan funding","bullets":["Nuo Therapeutics received the $325,000 Second Funding on October 6, 2026, bringing aggregate Lender funding under the Loan Agreement to $2,000,000.","The Second Closing Date was moved from September 30 to October 6, 2026 via an Assignment, Joinder, and Amendment No. 1.","Scott M. Pittman, a director and >10% beneficial owner, assumed $25,000 and received warrants for 4,500 shares, 458 prepayment shares, and up to 2,750 interest shares.","Second Notes bear 12% annual interest, mature December 31, 2028, and Assuming Lenders received warrants for 18,000 shares plus 1,832 prepayment shares.","Three new unaffiliated lenders joined, and four Assuming Lenders took the assigned $100,000 Second Funding commitment in equal $25,000 portions."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-26-032242","json":"https://secwatch.observer/filing/0001437749-26-032242.json","markdown":"https://secwatch.observer/filing/0001437749-26-032242.md","text":"https://secwatch.observer/filing/0001437749-26-032242.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1091596/000143774926032242/0001437749-26-032242-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1091596/000143774926032242/aurx20261006c_8k.htm"},"model":{"generated_by":"deepseek-v4.1-flash:cloud@v2","generated_at":"2026-10-12T16:11:07.234799+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}